Parametric Portfolio Associates’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
AVLSA
GC
ACM
Parametric Portfolio Associates's TECX Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Tectonic Therapeutic (TECX) stake by 25% in Q1 2022, buying an estimated $29.4K and bringing the position to 7,011 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.
Parametric Portfolio Associates first reported a position in TECX in Q1 2021 and has held it in 5 quarters since. The position peaked at $286K in Q3 2021. 80 funds tracked by Wall St. Rank hold TECX as of Q1 2022.
- Parametric Portfolio Associates held 7,011 shares of Tectonic Therapeutic worth $111K as of Q1 2022.
- Parametric Portfolio Associates bought 1,421 Tectonic Therapeutic shares in Q1 2022, an estimated $29.4K.
- Tectonic Therapeutic made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3551 holding.
- Parametric Portfolio Associates first reported a position in Tectonic Therapeutic in Q1 2021 and has held it in 5 quarters since.
- Parametric Portfolio Associates's Tectonic Therapeutic position peaked at $286K in Q3 2021.
- 80 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.